Follow
Mohammad Javad Hajipour
Mohammad Javad Hajipour
School of Medicine, Stanford University
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Antibacterial properties of nanoparticles
MJ Hajipour, KM Fromm, AA Ashkarran, DJ de Aberasturi, ...
Trends in biotechnology 30 (10), 499-511, 2012
29052012
Personalized protein coronas: a “key” factor at the nanobiointerface
MJ Hajipour, S Laurent, A Aghaie, F Rezaee, M Mahmoudi
Biomaterials science 2 (9), 1210-1221, 2014
2832014
Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide
MJ Hajipour, J Raheb, O Akhavan, S Arjmand, O Mashinchian, ...
Nanoscale 7 (19), 8978-8994, 2015
2242015
Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier
S Krol, R Macrez, F Docagne, G Defer, S Laurent, M Rahman, ...
Chemical reviews 113 (3), 1877-1903, 2013
2112013
Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges
Z Bakhtiary, AA Saei, MJ Hajipour, M Raoufi, O Vermesh, M Mahmoudi
Nanomedicine: Nanotechnology, Biology and Medicine 12 (2), 287-307, 2016
2012016
Advances in alzheimer’s diagnosis and therapy: The implications of nanotechnology
MJ Hajipour, MR Santoso, F Rezaee, H Aghaverdi, M Mahmoudi, G Perry
Trends in biotechnology 35 (10), 937-953, 2017
1362017
Protocol design for large–scale cross–sectional studies of surveillance of risk factors of non–communicable diseases in Iran: STEPs 2016
S Djalalinia, M Modirian, A Sheidaei, M Yoosefi, H Zokaiee, B Damirchilu, ...
Archives of Iranian medicine 20 (9), -, 2017
1202017
Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process
S Mirsadeghi, R Dinarvand, MH Ghahremani, MR Hormozi-Nezhad, ...
Nanoscale 7 (11), 5004-5013, 2015
1202015
Nanomedicine in healing chronic wounds: opportunities and challenges
S Sharifi, MJ Hajipour, L Gould, M Mahmoudi
Molecular pharmaceutics 18 (2), 550-575, 2020
1052020
Bypassing protein corona issue on active targeting: zwitterionic coatings dictate specific interactions of targeting moieties and cell receptors
R Safavi-Sohi, S Maghari, M Raoufi, SA Jalali, MJ Hajipour, ...
ACS applied materials & interfaces 8 (35), 22808-22818, 2016
1012016
Nanotoxicology: advances and pitfalls in research methodology
M Azhdarzadeh, AA Saei, S Sharifi, MJ Hajipour, AM Alkilany, ...
Nanomedicine 10 (18), 2931-2952, 2015
932015
Impact of gold nanoparticles on amyloid β-induced Alzheimer’s disease in a rat animal model: Involvement of STIM proteins
M Sanati, F Khodagholi, S Aminyavari, F Ghasemi, M Gholami, ...
ACS chemical neuroscience 10 (5), 2299-2309, 2019
852019
Disease-specific protein corona sensor arrays may have disease detection capacity
G Caracciolo, R Safavi-Sohi, R Malekzadeh, H Poustchi, M Vasighi, ...
Nanoscale Horizons 4 (5), 1063-1076, 2019
762019
Salt intake among Iranian population: the first national report on salt intake in Iran
S Rezaei, Z Mahmoudi, A Sheidaei, Z Aryan, N Mahmoudi, K Gohari, ...
Journal of hypertension 36 (12), 2380-2389, 2018
752018
Disease-related metabolites affect protein–nanoparticle interactions
M Tavakol, A Montazeri, R Naghdabadi, MJ Hajipour, S Zanganeh, ...
Nanoscale 10 (15), 7108-7115, 2018
652018
Probing fibronectin conformation on a protein corona layer around nanoparticles
M Raoufi, MJ Hajipour, SMK Shahri, I Schoen, U Linn, M Mahmoudi
Nanoscale 10 (3), 1228-1233, 2018
612018
The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016
Z Aryan, N Mahmoudi, A Sheidaei, S Rezaei, Z Mahmoudi, K Gohari, ...
Journal of clinical lipidology 12 (6), 1471-1481. e4, 2018
542018
Mechanistic understanding of the interactions between nano-objects with different surface properties and α-synuclein
H Mohammad-Beigi, A Hosseini, M Adeli, MR Ejtehadi, G Christiansen, ...
ACS nano 13 (3), 3243-3256, 2019
522019
Zeolite nanoparticles inhibit Aβ–fibrinogen interaction and formation of a consequent abnormal structural clot
H Derakhshankhah, MJ Hajipour, E Barzegari, A Lotfabadi, M Ferdousi, ...
ACS applied materials & interfaces 8 (45), 30768-30779, 2016
512016
A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
O Tabatabaei-Malazy, S Saeedi Moghaddam, N Rezaei, A Sheidaei, ...
PloS one 16 (3), e0241926, 2021
502021
The system can't perform the operation now. Try again later.
Articles 1–20